Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Julie A. Panepinto MD, MSPH

Julie A. Panepinto MD, MSPH

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Hematology

Member of the Cancer Center


I am willing to mentor a junior faculty member.


Clinical Expertise

  • Anemia, Sickle Cell
  • Hematology
  • Publications

  • Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. (King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR) Am J Hematol 2014 Oct;89(10):E188-92 PMID 25042018
  • Clinically Meaningful Interpretation of Pediatric Health-related Quality of Life in Sickle Cell Disease. (Beverung LM, Varni JW, Panepinto JA) J Pediatr Hematol Oncol 2014 Jun 17: PMID 24942019
  • Ambulatory quality indicators to prevent infection in sickle cell disease. (Beverung LM, Brousseau D, Hoffmann RG, Yan K, Panepinto JA) Am J Hematol 2014 Mar;89(3):256-60 PMID 24779032
  • Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease. (Wiczling P, Liem RI, Panepinto JA, Garg U, Abdel-Rahman SM, Kearns GL, Neville KA) J Clin Pharmacol 2014 Sep;54(9):1016-22 PMID 24729271
  • Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. (Badaki-Makun O, Scott JP, Panepinto JA, Casper TC, Hillery CA, Dean JM, Brousseau DC, Pediatric Emergency Care Applied Research Network (PECARN) Magnesium in Sickle Cell Crisis (MAGiC) Study Group) Pediatr Blood Cancer 2014 Jun;61(6):1049-54 PMID 24443249
  • Neuropathic pain in patients with sickle cell disease. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2014 Mar;61(3):512-7 PMID 24167104
  • PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. (Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW) Pediatr Blood Cancer 2014 Jan;61(1):171-7 PMID 24038960
  • Academic attainment findings in children with sickle cell disease. (Epping AS, Myrvik MP, Newby RF, Panepinto JA, Brandow AM, Scott JP) J Sch Health 2013 Aug;83(8):548-53 PMID 23834606
  • Clinically meaningful measurement of pain in children with sickle cell disease. (Myrvik MP, Brandow AM, Drendel AL, Yan K, Hoffmann RG, Panepinto JA) Pediatr Blood Cancer 2013 Oct;60(10):1689-95 PMID 23776145
  • Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion. (Collins CL, Scott JP, Panepinto JA, Punzalan RC) J Pediatr Hematol Oncol 2013 Jul;35(5):e226-8 PMID 23459377
  • Assessment of communication modes in patients and families with sickle cell disease. (Anderson C, Torres S, Gokuli S, Brandow AM, Panepinto JA) Pediatr Blood Cancer 2013 May;60(5):887 PMID 23450782
  • PedsQL™ sickle cell disease module: feasibility, reliability, and validity. (Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW) Pediatr Blood Cancer 2013 Aug;60(8):1338-44 PMID 23441057
  • Health-related quality of life in patients with hemoglobinopathies. (Panepinto JA) Hematology Am Soc Hematol Educ Program 2012;2012:284-9 PMID 23233593
  • What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease? (Darbari DS, Panepinto JA) Hematology Am Soc Hematol Educ Program 2012;2012:290-1 PMID 23233594
  • Mental health disorders influence admission rates for pain in children with sickle cell disease. (Myrvik MP, Burks LM, Hoffman RG, Dasgupta M, Panepinto JA) Pediatr Blood Cancer 2013 Jul;60(7):1211-4 PMID 23151972
  • Patients with sickle cell disease have increased sensitivity to cold and heat. (Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA) Am J Hematol 2013 Jan;88(1):37-43 PMID 23115062
  • Health-related quality of life in sickle cell disease: past, present, and future. (Panepinto JA, Bonner M) Pediatr Blood Cancer 2012 Aug;59(2):377-85 PMID 22522407
  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72 PMID 22343376
  • Inpatient management of sickle cell pain: a 'snapshot' of current practice. (Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)) Am J Hematol 2012 Mar;87(3):333-6 PMID 22231150
  • Concentration of hospital care for acute sickle cell disease-related visits. (Panepinto JA, Owens PL, Mosso AL, Steiner CA, Brousseau DC) Pediatr Blood Cancer 2012 Oct;59(4):685-9 PMID 22180290
  • Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. (DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF) Blood 2012 Apr 19;119(16):3684-90 PMID 22096242
  • When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department. (Hemker BG, Brousseau DC, Yan K, Hoffmann RG, Panepinto JA) Am J Hematol 2011 Oct;86(10):863-5 PMID 21815184
  • Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. (Brandow AM, Panepinto JA) Am J Hematol 2011 Sep;86(9):804-6 PMID 21815183
  • Development of the PedsQL™ Sickle Cell Disease Module items: qualitative methods. (Panepinto JA, Torres S, Varni JW) Qual Life Res 2012 Mar;21(2):341-57 PMID 21638090
  • Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. (Thornburg CD, Calatroni A, Panepinto JA) J Pediatr Hematol Oncol 2011 May;33(4):251-4 PMID 21516020
  • Outpatient follow-up and rehospitalizations for sickle cell disease patients. (Leschke J, Panepinto JA, Nimmer M, Hoffmann RG, Yan K, Brousseau DC) Pediatr Blood Cancer 2012 Mar;58(3):406-9 PMID 21495162
  • The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. (Brandow AM, Weisman SJ, Panepinto JA) Pediatr Blood Cancer 2011 May;56(5):789-93 PMID 21370412
  • The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. (Brandow AM et al.) Pediatr Blood Cancer 2010 Dec 15: PMID 21162071
  • Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. (Brandow AM, Panepinto JA) Expert Rev Hematol 2010 Jun;3(3):255-60 PMID 21082977
  • Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. (Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR) Blood 2011 Jan 20;117(3):772-9 PMID 20940417
  • Transition From Pediatric to Adult Care for Patients With Sickle Cell Disease-Reply. (Brousseau DC, Panepinto JA, Steiner CA) JAMA 2010 Jul 28;304(4):408-409 PMID 22618679
  • Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. (Brandow AM, Jirovec DL, Panepinto JA) Am J Hematol 2010 Aug;85(8):611-3 PMID 20658592
  • The effect of parental mental health on proxy reports of health-related quality of life in children with sickle cell disease. (Panepinto JA, Hoffmann RG, Pajewski NM) Pediatr Blood Cancer 2010 Oct;55(4):714-21 PMID 20589646
  • Acute care utilization and rehospitalizations for sickle cell disease. (Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA) JAMA 2010 Apr 7;303(13):1288-94 PMID 20371788
  • The number of people with sickle-cell disease in the United States: national and state estimates. (Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG) Am J Hematol 2010 Jan;85(1):77-8 PMID 20029951
  • Vaso-occlusive painful events in sickle cell disease: impact on child well-being. (Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA) Pediatr Blood Cancer 2010 Jan;54(1):92-7 PMID 19653296
  • A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease. (Panepinto JA, Hoffmann RG, Pajewski NM) Health Qual Life Outcomes 2009;7:32 PMID 19371442
  • Dissatisfaction with hospital care for children with sickle cell disease not due only to race and chronic disease. (Brousseau DC, Mukonje T, Brandow AM, Nimmer M, Panepinto JA) Pediatr Blood Cancer 2009 Aug;53(2):174-8 PMID 19350642
  • Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. (Brandow AM, Brousseau DC, Panepinto JA) Br J Haematol 2009 Mar;144(5):782-8 PMID 19055663
  • Impact of family income and sickle cell disease on the health-related quality of life of children. (Panepinto JA, Pajewski NM, Foerster LM, Sabnis S, Hoffmann RG) Qual Life Res 2009 Feb;18(1):5-13 PMID 18989755
  • The performance of the PedsQL generic core scales in children with sickle cell disease. (Panepinto JA, Pajewski NM, Foerster LM, Hoffmann RG) J Pediatr Hematol Oncol 2008 Sep;30(9):666-73 PMID 18776758
  • Parental perception of quality of hospital care for children with sickle cell disease. (Kam J, Panepinto JA, Brandow AM, Brousseau DC) WMJ 2008 May;107(3):131-5 PMID 18575097
  • Health-related quality of life in sickle cell disease. (Panepinto JA) Pediatr Blood Cancer 2008 Jul;51(1):5-9 PMID 18338399
  • The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis. (Brousseau DC, McCarver DG, Drendel AL, Divakaran K, Panepinto JA) J Pediatr 2007 Jun;150(6):623-6 PMID 17517247
  • Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay. (Goers T, Panepinto J, Debaun M, Blinder M, Foglia R, Oldham KT, Field JJ) Pediatr Blood Cancer 2008 Mar;50(3):603-6 PMID 17480009
  • Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. (Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):479-85 PMID 17459050
  • Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. (Hulbert ML, Scothorn DJ, Panepinto JA, Scott JP, Buchanan GR, Sarnaik S, Fallon R, Chu JY, Wang W, Casella JF, Resar L, Berman B, Adamkiewicz T, Hsu LL, Smith-Whitley K, Mahoney D, Woods G, Watanabe M, DeBaun MR) J Pediatr 2006 Nov;149(5):710-2 PMID 17095350
  • Attitudes regarding fertility preservation in female adolescent cancer patients. (Burns KC, Boudreau C, Panepinto JA) J Pediatr Hematol Oncol 2006 Jun;28(6):350-4 PMID 16794502
  • The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease. (Pawar SS, Panepinto JA, Brousseau DC) Pediatr Blood Cancer 2008 Jan;50(1):111-3 PMID 16619223
  • Perioperative management of sickle cell disease children undergoing adenotonsillectomy. (Duke RL, Scott JP, Panepinto JA, Flanary VA) Otolaryngol Head Neck Surg 2006 Mar;134(3):370-3 PMID 16500429
  • Acute idiopathic thrombocytopenic purpura of childhood-diagnosis and therapy. (Panepinto JA, Brousseau DC) Pediatr Emerg Care 2005 Oct;21(10):691-5; quiz 696-8 PMID 16215478
  • Health-related quality of life in children with sickle cell disease: child and parent perception. (Panepinto JA, O'Mahar KM, DeBaun MR, Loberiza FR, Scott JP) Br J Haematol 2005 Aug;130(3):437-44 PMID 16042695
  • Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. (Panepinto JA, Brousseau DC, Hillery CA, Scott JP) Pediatr Blood Cancer 2005 Feb;44(2):182-6 PMID 15390359
  • The effect of magnesium on length of stay for pediatric sickle cell pain crisis. (Brousseau DC, Scott JP, Hillery CA, Panepinto JA) Acad Emerg Med 2004 Sep;11(9):968-72 PMID 15347549
  • Validity of the child health questionnaire for use in children with sickle cell disease. (Panepinto JA, O'Mahar KM, DeBaun MR, Rennie KM, Scott JP) J Pediatr Hematol Oncol 2004 Sep;26(9):574-8 PMID 15342984
  • Pathophysiology of stroke in sickle cell disease. (Hillery CA, Panepinto JA) Microcirculation 2004 Mar;11(2):195-208 PMID 15280092
  • Clinical features of a human Rac2 mutation: a complex neutrophil dysfunction disease. (Kurkchubasche AG, Panepinto JA, Tracy TF Jr, Thurman GW, Ambruso DR) J Pediatr 2001 Jul;139(1):141-7 PMID 11445809
  • Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. (Ambruso DR, Knall C, Abell AN, Panepinto J, Kurkchubasche A, Thurman G, Gonzalez-Aller C, Hiester A, deBoer M, Harbeck RJ, Oyer R, Johnson GL, Roos D) Proc Natl Acad Sci U S A 2000 Apr 25;97(9):4654-9 PMID 10758162
  • Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis. (Panepinto JA, Magid D, Rewers MJ, Lane PA) J Pediatr 2000 Feb;136(2):201-8 PMID 10657826
  • Grants and Awards

  • Longitudinal Sit Trial Plasma Preteomic Biomarker Discovery and Validation in SCI (#9206976 01/01/2011 - 12/31/2014) Sponsor: Washington University in St Louis
  • Clinical Effectiveness Research-Improving the Value of Health Care (#9520288 10/01/2013 - 05/31/2016) Sponsor: AHW-Research and Education Program
  • Quality of Life After Treatment with Magnesium for Acute Sickle Cell Pain Episode (#9206765 01/18/2011 - 11/30/2014) Sponsor: NIH Heart Lung and Blood Institute
  • Silent Cerebral Infarct Multi-center Clinical Trial (#9203207 09/30/2003 - 11/30/2004) Sponsor: Washington University in St Louis
  • Sickle Cell Treatment Demonstration Program (#9208893 09/01/2014 - 08/31/2017) Sponsor: Cincinnati Children's Hospital Medical Center